In contrast, patients who possessed one or more SE allele had a 2.4-fold increase in odds of having PAD4 antibodies, and those with RA disease duration greater than 10 years were more likely to have PAD4 antibodies by a factor of 3.6 (p <  0.01 for both). The gene discussed is PADI4; the disease is rheumatoid arthritis.